Kazia Investor Relations have a different timetable to the rest of us. Landed in the inbox about an hour ago. Interesting last sentence, though. Is that a faint heartbeat I can hear....
News Alert
Dear Shareholder,
We wanted to share with you an article from the Sydney Morning Herald newspaper that very beautifully tells the story of Associate Professor Matt Dun, his wife Phoebe and their daughter Jose’s battle with DIPG. Kazia has been very privileged to work with Matt and his dedicated team at the University of Newcastle over the past three years in their fight against this deadly childhood brain cancer. This article, which details Matt and his family’s journey, is a poignant reminder of why we do what we do at Kazia. You can read the article here.
We are also pleased to share with you a recent interview on Proactive, where CEO Dr Garner discusses the publication of positive preclinical data for EVT801 peer-reviewed journal, Cancer Research Communications. Dr Garner also provides an update on both the EVT-801 and paxalisib clinical programs and upcoming milestones. You can view the video interview here.
We look forward to further updates soon.
Kind regards,
Kazia Investor Relations
